TXN and acute promyelocytic leukemia: In a diverse set of leukemia patients, such as patients affected by acute promyelocytic leukemia (APL), arsenic trioxide was also reported to increase ROS generation via NOX stimulation and thioredoxin reduction [59], and a recent in vitro experiment proved that leukemic cell death was correlated with enhanced OS and ROS generation.